Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Fátima Cardoso(Breast Cancer Alliance), Elżbieta Senkus(Gdańsk Medical University), S. Kyriakides, Sophia Zackrisson(Lund University), Shinji Ohno(Unknown), Philip Poortmans(University of Antwerp), Frédérique Penault‐Llorca(Inserm), Isabel T. Rubio(Clinica Universidad de Navarra)
Cited by 2,230
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k